Problems with Salvage

• Cross-resistance with previous drugs

• Multi-drug regimens (MegaHAART) difficult to tolerate

• New agents usually available one at a time

  • Exception, 1998: efavirenz, abacavir, adefovir
  • DCPG:  patients enrolled

Previous slide

Next slide

Back to first slide

View graphic version